Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies | MicrobiomeTrials← Back to trialsNCT02579967
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2015-11-19Est. Completion: 2031-12-31
Enrollment target: 354 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
- National Marrow Donor Program, Minneapolis, Minnesota, United States
Other microbiome trials you might be interested in
HIV
There is evidence that early and aggressive treatment with antiretroviral drugs can prevent the loss of immune cell func…
Bethesda, United States
Primary Immune Deficiency
This study will determine the biochemical and genetic causes of inherited immune diseases affecting lymphocyte homeostas…
Bethesda, United States
SCID
The investigators want to study if lower doses of chemotherapy will help babies with SCID to achieve good immunity with …
Birmingham, United StatesEst. completion Dec 1, 2027